Technique for PBSC harvesting in children of weight under 10 kg

被引:16
作者
Korístek, Z
Sterba, J
Havranová, D
Mayer, J
机构
[1] Univ Hosp, Dept Internal Med Hematooncol, Brno 63900, Czech Republic
[2] Masaryk Univ Hosp, Dept Pediat Oncol, Brno, Czech Republic
[3] Masaryk Univ Hosp, Tissue Bank, Brno, Czech Republic
关键词
PBSC; children; harvest; mobilization;
D O I
10.1038/sj/bmt/1703334
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Peripheral blood stem cell (PBSC) harvesting in the smallest children (weight <10 kg) using separators is complicated by specific problems. The volume of the separation set exceeds 25% of the total blood volume and the vascular access is generally not sufficient. Therefore, a simple manual technique for PBSC harvesting was developed. Three children (6-9 kg), with newly diagnosed tumours were scheduled to be treated with three to six sequential courses of high-dose chemotherapy, each followed by PBSC support. PBSC harvests were started after mobilization using cyclophosphamide and G-CSF when the peripheral blood CD34(+) cell count exceeded 50/mul. About 50 ml of blood was drawn from a venous catheter, injected into a transfer bag containing ACD-A, and centrifuged. The buffy coat obtained was pooled in a collection bag, remaining plasma and erythrocytes were immediately reinfused and a subsequent cycle started. From three to 13 cycles were performed in 1-3 days and 18.0-32.2 x 10(6) CD34(+) cells/kg were collected. We did not detect any bacterial contamination or any notable complications. Fifteen PBSC reinfusions have been performed to date, each with rapid engraftment taking between 7 and 13 days. Patients are in very good PR (18 months from diagnosis) or in CR (6 and 8 months). We can conclude that this procedure is feasible and safe.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 24 条
[1]   A PHASE-I AND PHASE-II TRIAL OF DOSE-INTENSIFIED CYCLOPHOSPHAMIDE AND GM-CSF IN PEDIATRIC MALIGNANT BRAIN-TUMORS [J].
ABRAHAMSEN, TG ;
LANGE, BJ ;
PACKER, RJ ;
VENZON, DJ ;
ALLEN, JC ;
CRAIG, CE ;
PATRONAS, NJ ;
KATZ, DA ;
GOLDWEIN, JW ;
DELANEY, TF ;
REAMAN, GH ;
PERILONGO, G ;
PHILLIPS, PC ;
OLDFIELD, EH ;
POPLACK, DG ;
HOROWITZ, ME .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1995, 17 (02) :134-139
[2]  
Alegre A, 1996, BONE MARROW TRANSPL, V17, P923
[3]  
AUQUIER P, 1995, BONE MARROW TRANSPL, V16, P541
[4]  
DEMEOCQ F, 1994, BONE MARROW TRANSPL, V13, P43
[5]   Peripheral blood progenitor cell collection by large-volume leukapheresis in low-weight children [J].
Diaz, MA ;
Alegre, A ;
Benito, A ;
Villa, M ;
Madero, L .
JOURNAL OF HEMATOTHERAPY, 1998, 7 (01) :63-68
[6]   WHERE DO WE STAND WITH RESPECT TO THE USE OF PERIPHERAL-BLOOD PROGENITOR CELLS [J].
GIANNI, AM .
ANNALS OF ONCOLOGY, 1994, 5 (09) :781-784
[7]  
Gorlin JB, 1996, J CLIN APHERESIS, V11, P195, DOI 10.1002/(SICI)1098-1101(1996)11:4<195::AID-JCA4>3.0.CO
[8]  
2-6
[9]   The relation between the number of PBSC and number of leukaphereses in children [J].
Kajiume, T ;
Yoshimi, S ;
Kobayashi, K ;
Kataoka, N .
JOURNAL OF HEMATOTHERAPY, 1999, 8 (02) :185-188
[10]   A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF [J].
Knudsen, LM ;
Jensen, L ;
Gaarsdal, E ;
Nikolaisen, K ;
Johnsen, HE .
BONE MARROW TRANSPLANTATION, 2000, 26 (07) :717-722